MedTech Dive November 21, 2022
Nick Paul Taylor

Dive Brief:

  • H2o Therapeutics has received 510(k) clearance for an Apple Watch app that monitors Parkinson’s disease symptoms such as tremors and dyskinesia.
  • The smartwatch app uses Apple’s movement disorder API and the inertial sensors of the device to provide insights into patients’ symptoms between visits to their clinicians.
  • Apple validated the technology in a clinical trial, positioning h2o to create an app that enables the sharing of objective Parkinson’s symptom data between patients and medical professionals.

Dive Insight:

Apple laid the foundation for the app last year by publishing the results of a clinical trial of 343 people with Parkinson’s disease. The tech company ran the study to evaluate its Motor fluctuations Monitor for Parkinson’s Disease (MM4PD)...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

Continue Reading

 
Topics: Apps, Digital Health, FDA, Govt Agencies, Technology, Wearables
Related Articles:
Key Benefits of CGM Technology
'We can nip a pandemic in the bud with smartwatches'
Flattening the curve: How smartwatches could help stop a pandemic before it even begins
Unlocking the power of sensor data in type 2 diabetes care
Google’s Pixel Watch 3 Loss of Pulse Detection Feature Receives FDA Clearance

Share This Article